查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946730

PD-L1 和 PIK3CA 检测全球市场报告（2026 年）

PD-L1 And PIK3CA Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，PD-L1和PIK3CA检测市场发展迅速，预计将从2025年的16.7亿美元成长到2026年的19.3亿美元，复合年增长率（CAGR）为15.5%。过去几年的成长可归因于PD-L1和PIK3CA检测方法的开发、其在临床试验中的广泛应用、癌症发生率的上升、分子诊断技术的进步以及人们对个人化治疗认识的不断提高。

预计未来几年，PD-L1 和 PIK3CA 检测市场将快速成长，到 2030 年市场规模将达到 34 亿美元，复合年增长率 (CAGR) 为 15.2%。预测期内的成长要素包括人工智慧在生物标记检测中的应用、液态生物检体应用的扩展、精准肿瘤学的进步、诊断公司与製药公司之间的合作以及下一代检测方法的监管核准。预测期内的关键趋势包括标靶癌症生物标记检测、基于人工智慧的突变分析、液态生物检体的应用、与药物研发流程的整合以及高通量基因组筛检。

癌症发生率的不断上升预计将推动PD-L1和PIK3CA检测市场的扩张。癌症的特征是异常细胞不受控制地生长和扩散，由于生活方式相关的风险因素和人口老化等因素，癌症的发生率正在上升。这些因素导致诊断率上升，进而增加了对早期检测和有效治疗方案的需求。 PD-L1和PIK3CA检测透过提供准确的诊断和指南标靶治疗，从而有助于癌症管理，实现个人化治疗。这将使治疗方案能够针对每位患者量身定制，并改善临床疗效。例如，根据美国癌症协会2024年9月发布的预测，全球男性癌症病例数预计将显着增加，从2022年的1,030万例增加至2029年的1,900万例，增幅达84%。癌症病例的快速成长正在推动PD-L1和PIK3CA检测市场的成长。

PD-L1 和 PIK3CA 检测市场的主要企业正致力于技术创新，特别是伴随诊断的整合，以改善治疗标靶性并提高癌症治疗的疗效。伴随诊断整合是指利用与标靶治疗协同设计的先进检测系统，根据患者的生物标记谱识别出最能从特定治疗中获益的患者群。例如，2024 年 10 月，总部位于瑞士的生物技术和製药公司罗氏（F. Hoffmann-La Roche AG）推出了 Itobevi（inavolisib）联合治疗Palbociclib和 fulvestrant 的方案，用于治疗内分泌抗药性、PIK3CA 突变、HR 阳性、HER2 阴性患者的进行性或转移性乳癌患者。 FDA 基于 III 期 INAVO120 试验的结果核准了该治疗方法，该试验表明，与单独使用Palbociclib和 fulvestrant 相比，该方案可使无恶化生存期延长两倍以上。这是罗氏首个针对 HR 阳性疾病的标靶治疗，其中包含用于识别合格患者的伴随诊断，代表着精准医疗在治疗选择有限的患者群体中取得的重大进展。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球PD-L1和PIK3CA检测市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 标靶癌症生物标记检测
    • 基于人工智慧的突变分析
    • 液态生物检体简介
    • 与药物研发部门合作
    • 高通量基因组筛检

第五章 终端用户产业市场分析

  • 医院
  • 研究所
  • 製药公司
  • 研究所
  • 诊断中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球PD-L1和PIK3CA检测市场：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球PD-L1及PIK3CA检测市场规模、比较及成长率分析
  • 全球PD-L1和PIK3CA检测市场表现：规模和成长，2020-2025年
  • 全球PD-L1和PIK3CA检测市场预测：规模和成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按测试类型
  • 免疫组织化学、次世代定序、聚合酵素链锁反应
  • 依样本类型
  • 组织样本、液态生物检体样本
  • 透过使用
  • 癌症诊断、药物开发、研究及其他应用
  • 最终用户
  • 医院、诊所、研究机构、製药公司
  • 按类型细分：免疫组织化学
  • 组织染色、蛋白质表现分析
  • 按类型细分：次世代定序
  • 全基因测序、标靶基因定序、EXOME定序、核糖核酸（RNA）定序
  • 按类型细分：聚合酵素链锁反应
  • 定量聚合酵素链锁反应，数位聚合酵素链锁反应

第十章 区域与国家分析

  • 全球PD-L1及PIK3CA检测市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球PD-L1和PIK3CA检测市场：国家/地区、效能和预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • PD-L1 和 PIK3CA 检测市场：竞争格局和市场份额，2024 年
  • PD-L1 和 PIK3CA 检测市场：公司估值矩阵
  • PD-L1 和 PIK3CA 检测市场：公司概况
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings（Labcorp）
    • Quest Diagnostics Incorporated

第37章：其他领先和创新企业

  • Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Myriad Genetics Inc., NeoGenomics Laboratories Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences, Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., ACCB Biotech Private Limited, EntroGen Inc.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年PD-L1和PIK3CA检测市场：提供新机会的国家
  • 2030 年 PD-L1 和 PIK3CA 检测市场：充满新机会的细分市场
  • 2030 年 PD-L1 和 PIK3CA 检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MPLPT01_G26Q1

PD-L1 and PIK3CA testing are molecular diagnostic methods used to identify specific biomarkers that support targeted cancer treatment decisions. PD-L1 testing measures the expression of the programmed death ligand 1 protein on tumor cells to evaluate the likelihood of response to immunotherapies. PIK3CA testing identifies mutations in the phosphatidylinositol 4,5 bisphosphate 3 kinase catalytic subunit alpha gene, which helps determine eligibility for therapies directed at the PI3K pathway.

The primary test types of PD-L1 and PIK3CA testing include immunohistochemistry, next generation sequencing, polymerase chain reaction, and others. Immunohistochemistry is a laboratory method that applies antibodies to detect specific proteins in tissue samples, making it possible to visualize their location and concentration under a microscope. The sample types used are tissue samples and liquid biopsy samples. The distribution channels include direct sales, distributors and resellers, and online sales platforms. The applications involve cancer diagnosis, drug development, research, and other uses, and they serve multiple end users such as hospitals and clinics, laboratories, and pharmaceutical companies.

Tariffs are impacting the pd-l1 and pik3ca testing market by increasing costs for imported sequencing kits, reagents, and diagnostic instruments. Hospitals, laboratories, and pharmaceutical companies in Asia-Pacific and Europe are most affected. Segments such as immunohistochemistry and next-generation sequencing kits face higher import costs. Positive impacts include promoting local manufacturing of reagents and kits, fostering innovation, and reducing dependency on international suppliers.

The pd-l1 and pik3ca testing market research report is one of a series of new reports from The Business Research Company that provides pd-l1 and pik3ca testing market statistics, including pd-l1 and pik3ca testing industry global market size, regional shares, competitors with a pd-l1 and pik3ca testing market share, detailed pd-l1 and pik3ca testing market segments, market trends and opportunities, and any further data you may need to thrive in the pd-l1 and pik3ca testing industry. This pd-l1 and pik3ca testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pd-l1 and pik3ca testing market size has grown rapidly in recent years. It will grow from $1.67 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to development of pd-l1 and pik3ca assays, adoption in clinical trials, growing cancer prevalence, advancements in molecular diagnostics, awareness of personalized therapy.

The pd-l1 and pik3ca testing market size is expected to see rapid growth in the next few years. It will grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to integration of ai in biomarker detection, growth of liquid biopsy applications, expansion in precision oncology, partnerships between diagnostics and pharma companies, regulatory approvals for next-gen assays. Major trends in the forecast period include targeted cancer biomarker testing, ai-based mutation analysis, liquid biopsy adoption, integration with drug development, high-throughput genomic screening.

The growing prevalence of cancer is expected to drive the expansion of the PD-L1 and PIK3CA testing market. Cancer, which is characterized by the uncontrolled growth and spread of abnormal cells, has become more common due to factors such as lifestyle-related risks and an aging population. These factors contribute to higher diagnosis rates and an increased demand for early detection and effective treatment solutions. PD-L1 and PIK3CA testing help manage cancer by providing accurate diagnoses and guiding targeted therapies, which allow treatments to be personalized to individual patients and improve clinical outcomes. For example, in September 2024, the American Cancer Society projected a significant increase in global cancer cases among men, estimating an 84% rise by 2029, from 10.3 million in 2022 to 19 million. This surge in cancer cases is driving the growth of the PD-L1 and PIK3CA testing market.

Key players in the PD-L1 and PIK3CA testing market are focusing on technological advancements, particularly the integration of companion diagnostics, to improve therapeutic targeting and enhance treatment efficacy in oncology. Companion diagnostic integration involves advanced testing systems designed alongside targeted medicines to identify patient groups most likely to benefit from specific treatments based on biomarker profiles. For instance, in October 2024, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology and pharmaceutical company, introduced Itovebi (inavolisib) in combination with palbociclib and fulvestrant for patients with endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative advanced or metastatic breast cancer. The FDA approved this regimen based on the Phase III INAVO120 study, which showed more than double the progression-free survival compared to palbociclib and fulvestrant alone. This marks Roche's first targeted therapy for HR-positive disease and incorporates a companion diagnostic to identify eligible patients, representing a major step forward in precision medicine for a patient population with limited treatment options.

In September 2025, Labcorp, a U.S.-based provider of comprehensive clinical laboratory services and drug development solutions, purchased select oncology and oncology-related clinical testing assets from BioReference Health for up to $225 million. Through this acquisition, Labcorp seeks to broaden its oncology diagnostics portfolio and enhance nationwide access to high-value cancer testing services by incorporating BioReference's specialized oncology capabilities and client accounts. BioReference Health is a U.S.-based provider of oncology-focused laboratory testing services, delivering advanced cancer diagnostics, clinical testing solutions, and regional clinical laboratory operations.

Major companies operating in the pd-l1 and pik3ca testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., NeoGenomics Laboratories Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences, Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., ACCB Biotech Private Limited, EntroGen Inc.

North America was the largest region in the PD-L1 and PIK3CA testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pd-l1 and pik3ca testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pd-l1 and pik3ca testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The PD-L1 and PIK3CA testing market includes revenues earned by entities through the biomarker testing, molecular diagnostics, genetic mutation detection, generation sequencing services, companion diagnostic testing, pathology interpretation, and clinical trial testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

PD-L1 And PIK3CA Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pd-l1 and pik3ca testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pd-l1 and pik3ca testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pd-l1 and pik3ca testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Immunohistochemistry; Next-Generation Sequencing; Polymerase Chain Reaction
  • 2) By Sample Type: Tissue Samples; Liquid Biopsy Samples
  • 3) By Applications: Cancer Diagnosis; Drug Development; Research; Other Applications
  • 4) By End User: Hospitals And Clinics; Laboratories; Pharmaceutical Companies
  • Subsegments:
  • 1) By Immunohistochemistry: Tissue Staining; Protein Expression Analysis
  • 2) By Next-Generation Sequencing: Whole Genome Sequencing; Targeted Gene Sequencing; Exome Sequencing; Ribonucleic Acid (RNA) Sequencing
  • 3) By Polymerase Chain Reaction: Quantitative Polymerase Chain Reaction; Digital Polymerase Chain Reaction
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Laboratory Corporation of America Holdings (Labcorp); Quest Diagnostics Incorporated; Eurofins Scientific SE; Agilent Technologies Inc.; Sonic Healthcare Limited; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Myriad Genetics Inc.; NeoGenomics Laboratories Inc.; BGI Genomics Co. Ltd.; Guardant Health Inc.; Caris Life Sciences; Foundation Medicine Inc.; Amoy Diagnostics Co. Ltd.; ACCB Biotech Private Limited; EntroGen Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pd-L1 And Pik3Ca Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pd-L1 And Pik3Ca Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pd-L1 And Pik3Ca Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pd-L1 And Pik3Ca Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Targeted Cancer Biomarker Testing
    • 4.2.2 Ai-Based Mutation Analysis
    • 4.2.3 Liquid Biopsy Adoption
    • 4.2.4 Integration With Drug Development
    • 4.2.5 High-Throughput Genomic Screening

5. Pd-L1 And Pik3Ca Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Laboratories
  • 5.3 Pharmaceutical Companies
  • 5.4 Research Institutes
  • 5.5 Diagnostic Centers

6. Pd-L1 And Pik3Ca Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pd-L1 And Pik3Ca Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pd-L1 And Pik3Ca Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pd-L1 And Pik3Ca Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pd-L1 And Pik3Ca Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pd-L1 And Pik3Ca Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pd-L1 And Pik3Ca Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pd-L1 And Pik3Ca Testing Market Segmentation

  • 9.1. Global Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunohistochemistry, Next-Generation Sequencing, Polymerase Chain Reaction
  • 9.2. Global Pd-L1 And Pik3Ca Testing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue Samples, Liquid Biopsy Samples
  • 9.3. Global Pd-L1 And Pik3Ca Testing Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer Diagnosis, Drug Development, Research, Other Applications
  • 9.4. Global Pd-L1 And Pik3Ca Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Laboratories, Pharmaceutical Companies
  • 9.5. Global Pd-L1 And Pik3Ca Testing Market, Sub-Segmentation Of Immunohistochemistry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue Staining, Protein Expression Analysis
  • 9.6. Global Pd-L1 And Pik3Ca Testing Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Whole Genome Sequencing, Targeted Gene Sequencing, Exome Sequencing, Ribonucleic Acid (RNA) Sequencing
  • 9.7. Global Pd-L1 And Pik3Ca Testing Market, Sub-Segmentation Of Polymerase Chain Reaction, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Quantitative Polymerase Chain Reaction, Digital Polymerase Chain Reaction

10. Pd-L1 And Pik3Ca Testing Market Regional And Country Analysis

  • 10.1. Global Pd-L1 And Pik3Ca Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pd-L1 And Pik3Ca Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pd-L1 And Pik3Ca Testing Market

  • 11.1. Asia-Pacific Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pd-L1 And Pik3Ca Testing Market

  • 12.1. China Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pd-L1 And Pik3Ca Testing Market

  • 13.1. India Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pd-L1 And Pik3Ca Testing Market

  • 14.1. Japan Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pd-L1 And Pik3Ca Testing Market

  • 15.1. Australia Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pd-L1 And Pik3Ca Testing Market

  • 16.1. Indonesia Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pd-L1 And Pik3Ca Testing Market

  • 17.1. South Korea Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pd-L1 And Pik3Ca Testing Market

  • 18.1. Taiwan Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pd-L1 And Pik3Ca Testing Market

  • 19.1. South East Asia Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pd-L1 And Pik3Ca Testing Market

  • 20.1. Western Europe Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pd-L1 And Pik3Ca Testing Market

  • 21.1. UK Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pd-L1 And Pik3Ca Testing Market

  • 22.1. Germany Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pd-L1 And Pik3Ca Testing Market

  • 23.1. France Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pd-L1 And Pik3Ca Testing Market

  • 24.1. Italy Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pd-L1 And Pik3Ca Testing Market

  • 25.1. Spain Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pd-L1 And Pik3Ca Testing Market

  • 26.1. Eastern Europe Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pd-L1 And Pik3Ca Testing Market

  • 27.1. Russia Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pd-L1 And Pik3Ca Testing Market

  • 28.1. North America Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pd-L1 And Pik3Ca Testing Market

  • 29.1. USA Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pd-L1 And Pik3Ca Testing Market

  • 30.1. Canada Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pd-L1 And Pik3Ca Testing Market

  • 31.1. South America Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pd-L1 And Pik3Ca Testing Market

  • 32.1. Brazil Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pd-L1 And Pik3Ca Testing Market

  • 33.1. Middle East Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pd-L1 And Pik3Ca Testing Market

  • 34.1. Africa Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pd-L1 And Pik3Ca Testing Market Regulatory and Investment Landscape

36. Pd-L1 And Pik3Ca Testing Market Competitive Landscape And Company Profiles

  • 36.1. Pd-L1 And Pik3Ca Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pd-L1 And Pik3Ca Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pd-L1 And Pik3Ca Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Laboratory Corporation of America Holdings (Labcorp) Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Pd-L1 And Pik3Ca Testing Market Other Major And Innovative Companies

  • Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., NeoGenomics Laboratories Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences, Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., ACCB Biotech Private Limited, EntroGen Inc.

38. Global Pd-L1 And Pik3Ca Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pd-L1 And Pik3Ca Testing Market

40. Pd-L1 And Pik3Ca Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Pd-L1 And Pik3Ca Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Pd-L1 And Pik3Ca Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Pd-L1 And Pik3Ca Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer